Showing results (291-300 of 614) with videos related to
Sort By:
Pageof 62
Ophthalmic Surgery, Lasers & Imaging Retina|August 21, 2020
Twenty-Four-Month OCTA Assessment in Diabetic Patients Undergoing Fixed-Interval Intravitreal Aflibercept TherapyBrittney Statler, Thais F Conti, Felipe F Conti, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 1, 1989
Kidney disease of diabetes mellitus: NIDDK initiatives for the comprehensive study of its natural history, pathogenesis, and preventionS C FitzSimmons, L Agodoa, L Striker, et al.Water Science and Technology : a Journal of the International Association on Water Pollution Research|October 4, 2002
Assessing the environmental impact of WWTP expansion: odour nuisance and its minimizationA G Capodaglio, F Conti, L Fortina, et al.Neuroscience|December 1, 2000
Etorphine increases the number of mu-opioid receptor-positive cells in the cerebral cortexM Melone, N C Brecha, C Sternini, et al.Atherosclerosis|April 1, 1977
Treatment of hypertriglyceridemia with metformin. Effectiveness and analỳsis of resultsC R Sirtori, E Tremoli, M Sirtori, et al.Pflugers Archiv : European Journal of Physiology|May 1, 1991
Gating currents of inactivating and non-inactivating potassium channels expressed in Xenopus oocytesW Stühmer, F Conti, M Stocker, et al.Journal of Bacteriology|August 1, 1970
Polar lipids of Chromatium strain D grown at different light intensitiesS Steiner, J C Burnham, S F Conti, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 1, 1995
GAT-1, a high-affinity GABA plasma membrane transporter, is localized to neurons and astroglia in the cerebral cortexA Minelli, N C Brecha, C Karschin, et al.European Cytokine Network|April 3, 2001
Increased cell surface expression of histocompatibility class II I-A(d) in c-fos transfected clones of the P388D1 murine macrophage cell lineY Le Garrec, E Rouer, F Conti, et al.La Clinica Terapeutica|April 5, 2007
[New combination chemotherapy regimens in the primary treatment of operable breast cancer]F Conti, D Sergi, P Foggi, et al.Pageof 62